First WHO model list of essential in vitro diagnostics

Overview

The three strategic priorities of WHO stated in its Thirteenth General Programme of Work 2019–2023 are to advance universal health coverage, address health emergencies and promote healthier populations.

The EDL will provide guidance and serve as a reference to ministries of health, programme managers, users such as laboratory managers, procurement officers and reimbursement systems in Member States, who are establishing or updating national lists of essential IVDs for universal health coverage. It will also inform United Nations agencies and nongovernmental organizations that support the selection, procurement, supply, donations or provision of IVDs. Finally, it will inform and guide the private sector for medical technology on IVD priorities and the IVDs needed to address global health issues.

The EDL comprises a group of IVDs that are recommended by WHO for use at various levels of a tiered national health care system. The List is not intended to be prescriptive with respect to the IVDs nor the levels at which they can or should be used. Countries should make their own decisions about which IVDs to select and where they are to be used on the basis of the national or regional burden of the disease, unmet needs, available resources and priorities.